{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T22:40:53Z","timestamp":1791499253883,"version":"4.3.4"},"reference-count":59,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2001,9,1]],"date-time":"2001-09-01T00:00:00Z","timestamp":999302400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2001,9,1]],"date-time":"2001-09-01T00:00:00Z","timestamp":999302400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Leukemia"],"published-print":{"date-parts":[[2001,9,1]]},"DOI":"10.1038\/sj.leu.2402203","type":"journal-article","created":{"date-parts":[[2002,9,19]],"date-time":"2002-09-19T21:06:15Z","timestamp":1032469575000},"page":"1339-1346","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":47,"title":["Induction of graft-versus-leukemia to prevent relapse after partially lymphocyte-depleted allogeneic bone marrow transplantation by pre-emptive donor leukocyte infusions"],"prefix":"10.1038","volume":"15","author":[{"given":"N","family":"Schaap","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A","family":"Schattenberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B","family":"B\u00e4r","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F","family":"Preijers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E","family":"van de Wiel van Kemenade","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T","family":"de Witte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2001,9,28]]},"reference":[{"key":"BF2402203_CR1","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/0140-6736(93)92526-Y","volume":"341","author":"D Blaise","year":"1993","unstructured":"Blaise D, Gravis G, Maraninchi D . Long-term follow-up of T-cell depletion for bone marrow transplantation (letter) Lancet 1993 341: 51\u201352","journal-title":"Lancet"},{"key":"BF2402203_CR2","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1097\/00001622-199407000-00006","volume":"6","author":"D Bron","year":"1994","unstructured":"Bron D . Graft-versus-host disease Curr Opin Oncol 1994 6: 358\u2013364","journal-title":"Curr Opin Oncol"},{"key":"BF2402203_CR3","first-page":"512","volume":"3","author":"N Gardiner","year":"1997","unstructured":"Gardiner N, Lawler M, O'Riordan J, De'Arce M, McCann SR . Donor chimaerism is a strong indicator of disease-free survival following bone marrow transplantation for chronic myeloid leukaemia Leukemia 1997 3: 512\u2013515","journal-title":"Leukemia"},{"key":"BF2402203_CR4","first-page":"447","volume":"11","author":"R Miralbell","year":"1993","unstructured":"Miralbell R, Chapuis B, Nouet P, Helg C, Delorme H, Wacker P, Wyss M, Kurtz J . Conditioning the leukemic patient before allogeneic BMT: value of intensifying immunosuppression in the context of different levels of T lymphocyte depletion of the graft Bone Marrow Transplant 1993 11: 447\u2013451","journal-title":"Bone Marrow Transplant"},{"key":"BF2402203_CR5","doi-asserted-by":"crossref","first-page":"3481","DOI":"10.1182\/blood.V91.9.3481","volume":"91","author":"R Powles","year":"1998","unstructured":"Powles R, Singhal S, Treleaven J, Kulkarni S, Horton C, Mehta J . Identification of patients who may benefit from prophylactic immunotherapy after bone marrow transplantation for acute myeloid leukemia on the basis of lymphocyte recovery early after transplantation Blood 1998 91: 3481\u20133486","journal-title":"Blood"},{"key":"BF2402203_CR6","doi-asserted-by":"publisher","first-page":"1205","DOI":"10.1038\/sj.bmt.1700824","volume":"19","author":"A Schattenberg","year":"1997","unstructured":"Schattenberg A, Preijers F, Mensink E, B\u00e4r B, Schaap N, Geurts van Kessel A, van der Maazen R, de Witte T . Survival in first or second remission after lymphocyte depleted transplantation for philadelphia chromosome positive CML in first chronic phase Bone Marrow Transplant 1997 19: 1205\u20131212","journal-title":"Bone Marrow Transplant"},{"key":"BF2402203_CR7","first-page":"407a","volume":"72","author":"S Slavin","year":"1988","unstructured":"Slavin S, Or R, Naparstek E, Eckerstein A, Weiss L . Cellular mediated immunotherapy of leukemia in conjuction with autologous and allogeneic bone marrow transplantation in experimental animals and man Blood 1988 72: 407a","journal-title":"Blood"},{"key":"BF2402203_CR8","first-page":"164","volume":"6","author":"S Slavin","year":"1992","unstructured":"Slavin S, Or R, Kapelushnik Y, Drakos P, Ackerstein A, Vourka-Karussis U, Weiss L, Nagler A . Immunotherapy of minimal residual disease in conjunction with autologous and allogeneic bone marrow transplantation Leukemia 1992 6: (Suppl.\u20094) 164\u2013166","journal-title":"Leukemia"},{"key":"BF2402203_CR9","doi-asserted-by":"crossref","first-page":"3059","DOI":"10.1182\/blood.V83.10.3059.3059","volume":"83","author":"JE van Leeuwen","year":"1994","unstructured":"van Leeuwen JE, van Tol MJ, Joosten AM, Wijnen JT, Verweij PJ, Khan PM, Vossen JM . Persistence of host-type hematopoiesis after allogeneic bone marrow transplantation for leukemia is significantly related to the recipient's age and\/or the conditioning regimen, but it is not associated with an increased risk of relapse Blood 1994 83: 3059\u20133067","journal-title":"Blood"},{"key":"BF2402203_CR10","first-page":"281","volume":"3","author":"O Ringden","year":"1988","unstructured":"Ringden O, Sundberg B, Lonnqvist B, Tollemar J, Gahrton G, Nilsson B . Allogeneic bone marrow transplantation for leukemia: factors of importance for long-term survival and relapse Bone Marrow Transplant 1988 3: 281\u2013290","journal-title":"Bone Marrow Transplant"},{"key":"BF2402203_CR11","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1111\/j.1365-2141.1986.tb05544.x","volume":"63","author":"J Patterson","year":"1986","unstructured":"Patterson J, Prentice HG, Brenner MK, Gilmore M, Janossy G, Ivory K, Skeggs D, Morgan H, Lord J, Blacklock HA, Hoffbrand AV, Apperley JF, Goldman JM, Burnett A, Gribben J, Alcorn M, Pearson C, McVickers I, Hann IM, Reid C, Wardle D, Gravett PJ, Bacigalupo A, Robertson AG . Graft rejection following HLA matched T-lymphocyte depleted bone marrow transplantation Br J Haematol 1986 63: 221\u2013230","journal-title":"Br J Haematol"},{"key":"BF2402203_CR12","first-page":"53","volume":"1","author":"JF Apperley","year":"1986","unstructured":"Apperley JF, Jones L, Hale G, Waldmann H, Hows J, Rombos Y, Tsatalas C, Marcus RE, Goolden AW, Gordon Smith, Catovsky D, Galton DAG, Goldman JM . Bone marrow transplantation for patients with chronic myeloid leukaemia: T-cell depletion with Campath-1 reduces the incidence of graft-versus-host disease but may increase the risk of leukaemic relapse Bone Marrow Transplant 1986 1: 53\u201366","journal-title":"Bone Marrow Transplant"},{"key":"BF2402203_CR13","doi-asserted-by":"publisher","first-page":"505","DOI":"10.7326\/0003-4819-116-6-505","volume":"116","author":"MM Bortin","year":"1992","unstructured":"Bortin MM, Horowitz MM, Rimm AA . Increasing utilization of allogeneic bone marrow transplantation. Results of the 1988\u20131990 survey Ann Intern Med 1992 116: 505\u2013512","journal-title":"Ann Intern Med"},{"key":"BF2402203_CR14","first-page":"43","volume":"16","author":"B Leclair","year":"1995","unstructured":"Leclair B, Fregeau CJ, Aye MT, Fourney RM . DNA typing for bone marrow engraftment follow-up after allogeneic transplant: a comparative study of current technologies Bone Marrow Transplant 1995 16: 43\u201355","journal-title":"Bone Marrow Transplant"},{"key":"BF2402203_CR15","first-page":"597","volume":"13","author":"G Hale","year":"1994","unstructured":"Hale G, Waldmann H . Control of graft-versus-host disease and graft rejection by T cell depletion of donor and recipient with Campath-1 antibodies. Results of matched sibling transplants for malignant diseases Bone Marrow Transplant 1994 13: 597\u2013611","journal-title":"Bone Marrow Transplant"},{"key":"BF2402203_CR16","first-page":"1553","volume":"23","author":"S Slavin","year":"1995","unstructured":"Slavin S, Naparstek E, Nagler A, Ackerstein A, Kapelushnik J, Or R . Allogeneic cell therapy for relapsed leukemia after bone marrow transplantation with donor peripheral blood lymphocytes Exp Hematol 1995 23: 1553\u20131562","journal-title":"Exp Hematol"},{"key":"BF2402203_CR17","doi-asserted-by":"publisher","first-page":"750","DOI":"10.1046\/j.1365-2141.1997.d01-3499.x","volume":"98","author":"N Schaap","year":"1997","unstructured":"Schaap N, Schattenberg A, B\u00e4r B, Preijers F, Geurts van Kessel A, van der Maazen R, de Boo T, de Witte T . Outcome of transplantation for standard risk leukaemia with grafts depleted of lymphocytes after conditioning with an intensified regimen Br J Haematol 1997 98: 750\u2013759","journal-title":"Br J Haematol"},{"key":"BF2402203_CR18","doi-asserted-by":"crossref","first-page":"3377","DOI":"10.1182\/blood.V83.11.3377.3377","volume":"83","author":"F Van Rhee","year":"1994","unstructured":"Van Rhee F, Lin F, Cullis JO, Spencer A, Cross NCP, Chase A, Garicochea B, Bungey J, Barret J, Goldman JM . Relapse of chronic myeloid leukemia after allogeneic bone marrow transplant: the case for giving donor leukocyte transfusions before the onset of hematologic relapse Blood 1994 83: 3377\u20133383","journal-title":"Blood"},{"key":"BF2402203_CR19","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1038\/sj.bmt.1701131","volume":"21","author":"AJ Barrett","year":"1998","unstructured":"Barrett AJ, Mavroudis D, Tisdale J, Molldrem J, Clave E, Dunbar C, Cottler F, Phang S, Carter C, Okunnieff P, Young NS, Read EJ . T cell-depleted bone marrow transplantation and delayed T cell add-back to control acute GVHD and conserve a graft-versus-leukemia effect Bone Marrow Transplant 1998 21: 543\u2013551","journal-title":"Bone Marrow Transplant"},{"key":"BF2402203_CR20","doi-asserted-by":"publisher","first-page":"301","DOI":"10.3109\/10428199809068567","volume":"29","author":"C Helg","year":"1998","unstructured":"Helg C, Starobinski M, Jeannet M, Chapuis B . Donor lymphocyte infusion for the treatment of relapse after allogeneic hematopoietic stem cell transplantation Leuk Lymphoma 1998 29: 301\u2013313","journal-title":"Leuk Lymphoma"},{"key":"BF2402203_CR21","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1097\/00007890-197309000-00004","volume":"16","author":"MM Bortin","year":"1973","unstructured":"Bortin MM, Rimm AA, Saltzstein EC, Rodey GE . Graft versus leukemia. Apparent independent antihost and antileukemia activity of transplanted immunocompetent cells Transplantation 1973 16: 182\u2013188","journal-title":"Transplantation"},{"key":"BF2402203_CR22","first-page":"219","volume-title":"Experimental Models and Clinical Trials","author":"RL Truitt","year":"1987","unstructured":"Truitt RL, Lefevre AV, Shih CC. Gale RP, Champlin R (eds) . Graft-vs-leukemia reactions Experimental Models and Clinical Trials Liss: New York 1987 pp 219\u2013232"},{"key":"BF2402203_CR23","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1182\/blood.V75.3.555.555","volume":"75","author":"MM Horowitz","year":"1990","unstructured":"Horowitz MM, Gale RP, Sondel PM, Goldman JM, Kersey J, Kolb HJ, Rimm AA, Ringden O, Rozman C, Speck B . Graft-versus-leukemia reactions after bone marrow transplantation Blood 1990 75: 555\u2013562","journal-title":"Blood"},{"key":"BF2402203_CR24","doi-asserted-by":"publisher","first-page":"477","DOI":"10.3109\/10428199609054857","volume":"23","author":"M Imamura","year":"1996","unstructured":"Imamura M, Hashino S, Tanaka J . Graft-versus-leukemia effect and its clinical implications Leuk Lymphoma 1996 23: 477\u2013492","journal-title":"Leuk Lymphoma"},{"key":"BF2402203_CR25","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3109\/10428199609054795","volume":"23","author":"BD Johnson","year":"1996","unstructured":"Johnson BD, Hanke CA, Truitt RL . The graft-versus-leukemia effect of post-transplant donor leukocyte infusion Leuk Lymphoma 1996 23: 1\u20139","journal-title":"Leuk Lymphoma"},{"key":"BF2402203_CR26","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1007\/BF00199267","volume":"11","author":"S Slavin","year":"1981","unstructured":"Slavin S, Weiss L, Morecki S, Weigensberg M . Eradication of murine leukemia with histo-incompatible marrow grafts in mice conditioned with total lymphoid irradiation (TLI) Cancer Immunol Immunother 1981 11: 155\u2013158","journal-title":"Cancer Immunol Immunother"},{"key":"BF2402203_CR27","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1182\/blood.V86.4.1261.bloodjournal8641261","volume":"86","author":"S Mackinnon","year":"1995","unstructured":"Mackinnon S, Papadopoulos EB, Carabasi MH, Reich L, Collins NH, Boulad F, Castro Malaspina, Childs BH, Gillio AP, Kernan NA . Adoptive immunotherapy evaluating escalating doses of donor leukocytes for relapse of chronic myeloid leukemia after bone marrow transplantation: separation of graft-versus-leukemia responses from graft-versus-host disease Blood 1995 86: 1261\u20131268","journal-title":"Blood"},{"key":"BF2402203_CR28","doi-asserted-by":"publisher","first-page":"828","DOI":"10.1056\/NEJM198903303201303","volume":"320","author":"KM Sullivan","year":"1989","unstructured":"Sullivan KM, Storb R, Buckner CD, Fefer A, Fisher L, Weiden PL, Witherspoon RP, Appelbaum FR, Banaji M, Hansen J, Martin P, Sanders JE, Singer J, Thomas D . Graft-versus-host disease as adoptive immunotherapy in patients with advanced hematologic neoplasms N Engl J Med 1989 320: 828\u2013834","journal-title":"N Engl J Med"},{"key":"BF2402203_CR29","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1111\/j.1365-2141.1995.tb08356.x","volume":"89","author":"E Naparstek","year":"1995","unstructured":"Naparstek E, Or R, Nagler A, Cividalli G, Engelhard D, Aker M, Gimon Z, Manny N, Sacks T, Tochner Z, Weiss L, Samuel S, Brautbar C, Hale G, Waldmann H, Steinberg SM, Slavin S . T-cell-depleted allogeneic bone marrow transplantation for acute leukaemia using Campath-1 antibodies and post-transplant administration of donor's peripheral blood lymphocytes for prevention of relapse Br J Haematol 1995 89: 506\u2013515","journal-title":"Br J Haematol"},{"key":"BF2402203_CR30","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1097\/00007890-198402000-00007","volume":"37","author":"T de Witte","year":"1984","unstructured":"de Witte T, Raymakers R, Plas A, Koekman E, Wessels H, Haanen C . Bone marrow repopulation capacity after transplantation of lymphocyte-depleted allogeneic bone marrow using counterflow centrifugation Transplantation 1984 37: 151\u2013155","journal-title":"Transplantation"},{"key":"BF2402203_CR31","first-page":"355","volume":"16","author":"A Plas","year":"1988","unstructured":"Plas A, de Witte T, Wessels H, Haanen C . A new multichamber counterflow centrifugation rotor with high-separation capacity and versatile potentials Exp Hematol 1988 16: 355\u2013359","journal-title":"Exp Hematol"},{"key":"BF2402203_CR32","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1097\/00007890-197410000-00001","volume":"18","author":"H Glucksberg","year":"1974","unstructured":"Glucksberg H, Storb R, Fefer A, Buckner CD, Neiman PE, Clift RA, Lerner KG, Thomas ED . Clinical manifestations of graft-versus-host disease in human recipients of marrow from HL-A-matched sibling donors Transplantation 1974 18: 295\u2013304","journal-title":"Transplantation"},{"key":"BF2402203_CR33","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1016\/0002-9343(80)90380-0","volume":"69","author":"HM Shulman","year":"1980","unstructured":"Shulman HM, Sullivan KM, Weiden PL, McDonald GB, Striker GE, Sale GE, Hackman R, Tsoi MS, Storb R, Thomas ED . Chronic graft-versus-host syndrome in man. A long-term clinicopathologic study of 20 Seattle patients Am J Med 1980 69: 204\u2013217","journal-title":"Am J Med"},{"key":"BF2402203_CR34","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1182\/blood.V73.5.1367.1367","volume":"73","author":"A Schattenberg","year":"1989","unstructured":"Schattenberg A, de Witte T, Salden M, Vet J, van Dijk B, Smeets D, Hoogenhout J, Haanen C . Mixed hematopoietic chimerism after allogeneic transplantation with lymphocyte-depleted bone marrow is not associated with a higher incidence of relapse Blood 1989 73: 1367\u20131372","journal-title":"Blood"},{"key":"BF2402203_CR35","doi-asserted-by":"publisher","first-page":"171","DOI":"10.3109\/10428199109068122","volume":"5","author":"A Schattenberg","year":"1991","unstructured":"Schattenberg A, B\u00e4r B, Vet J, Van Dijk B, Smeets D, de Witte T . Comparison of chimerism of red cells with that of granulocytes, T lymphocytes, and bone marrow cells in recipients of marrow depleted of lymphocytes using counterflow centrifugation Leuk Lymphoma 1991 5: 171\u2013177","journal-title":"Leuk Lymphoma"},{"key":"BF2402203_CR36","first-page":"91","volume":"11","author":"SR McCann","year":"1993","unstructured":"McCann SR, Lawler M . Mixed chimaerism; detection and significance following BMT Bone Marrow Transplant 1993 11: 91\u201394","journal-title":"Bone Marrow Transplant"},{"key":"BF2402203_CR37","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1111\/j.1365-2141.1989.tb07689.x","volume":"72","author":"BM B\u00e4r","year":"1989","unstructured":"B\u00e4r BM, Schattenberg A, Van Dijk BA, De Man AJ, Kunst VA, de Witte TM . Host and donor erythrocyte repopulation patterns after allogeneic bone marrow transplantation analysed with antibody-coated fluorescent microspheres Br J Haematol 1989 72: 239\u2013245","journal-title":"Br J Haematol"},{"key":"BF2402203_CR38","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1159\/000461828","volume":"55","author":"AJ De Man","year":"1988","unstructured":"De Man AJ, Foolen WJ, Van Dijk BA, Kunst VA, de Witte TM . A fluorescent microsphere method for the investigation of erythrocyte chimaerism after allogeneic bone marrow transplantation using antigenic differences Vox Sang 1988 55: 37\u201341","journal-title":"Vox Sang"},{"key":"BF2402203_CR39","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1046\/j.1365-2141.1997.d01-2138.x","volume":"97","author":"EC Hendriks","year":"1997","unstructured":"Hendriks EC, De Man AJ, van Berkel YC, Stienstra S, de Witte T . Flow cytometric method for the routine follow-up of red cell populations after bone marrow transplantation Br J Haematol 1997 97: 141\u2013145","journal-title":"Br J Haematol"},{"key":"BF2402203_CR40","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1200\/JCO.1993.11.3.513","volume":"11","author":"BM B\u00e4r","year":"1993","unstructured":"B\u00e4r BM, Schattenberg A, Mensink EJ, Geurts van Kessel A, Smetsers T, Knops G, Linders E, de Witte T . Donor leukocyte infusions for chronic myeloid leukemia relapsed after allogeneic bone marrow transplantation J Clin Oncol 1993 11: 513\u2013519","journal-title":"J Clin Oncol"},{"key":"BF2402203_CR41","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1080\/01621459.1958.10501452","volume":"53","author":"EL Kaplan","year":"1958","unstructured":"Kaplan EL, Meier P . Nonparametric estimation from incomplete observations Am Stat Assoc 1958 53: 457\u2013466","journal-title":"Am Stat Assoc"},{"key":"BF2402203_CR42","doi-asserted-by":"crossref","first-page":"3302","DOI":"10.1182\/blood.V85.11.3302.bloodjournal85113302","volume":"85","author":"BD Johnson","year":"1995","unstructured":"Johnson BD, Truitt RL . Delayed infusion of immunocompetent donor cells after bone marrow transplantation breaks graft-host tolerance allows for persistent antileukemic reactivity without severe graft-versus-host disease Blood 1995 85: 3302\u20133312","journal-title":"Blood"},{"key":"BF2402203_CR43","first-page":"591","volume":"15","author":"S Mackinnon","year":"1995","unstructured":"Mackinnon S, Papadopoulos EB, Carabasi MH, Reich L, Collins NH, O'Reilly RJ . Adoptive immunotherapy using donor leukocytes following bone marrow transplantation for chronic myeloid leukemia: is T cell dose important in determining biological response? Bone Marrow Transplant 1995 15: 591\u2013594","journal-title":"Bone Marrow Transplant"},{"key":"BF2402203_CR44","doi-asserted-by":"crossref","first-page":"2310","DOI":"10.1182\/blood.V82.8.2310.2310","volume":"82","author":"WR Drobyski","year":"1993","unstructured":"Drobyski WR, Keever CA, Roth MS, Koethe S, Hanson G, McFadden P, Gottschall JL, Ash RC, van Tuinen P, Horowitz MM . Salvage immunotherapy using donor leukocyte infusions as treatment for relapsed chronic myelogenous leukemia after allogeneic bone marrow transplantation: efficacy and toxicity of a defined T-cell dose Blood 1993 82: 2310\u20132318","journal-title":"Blood"},{"key":"BF2402203_CR45","doi-asserted-by":"crossref","first-page":"2041","DOI":"10.1182\/blood.V86.5.2041.bloodjournal8652041","volume":"86","author":"HJ Kolb","year":"1995","unstructured":"Kolb HJ, Schattenberg A, Goldman JM, Hertenstein B, Jacobsen N, Arcese W, Ljungman P, Ferrant A, Verdonck L, Niederwieser D, Van Rhee F, Mittermueller J, de Witte T, Holler E, Ansari H . Graft-versus-leukemia effect of donor lymphocyte transfusions in marrow grafted patients Blood 1995 86: 2041\u20132050","journal-title":"Blood"},{"key":"BF2402203_CR46","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1046\/j.1365-2141.2000.01803.x","volume":"108","author":"N Schaap","year":"2000","unstructured":"Schaap N, Schattenberg A, B\u00e4r B, Mensink E, de Man A, Geurts van Kessel A, de Witte T . Red blood cell phenotyping is a sensitive technique for monitoring chronic myeloid leukaemia patients after T-cell-depleted bone marrow transplantation and after donor leucocyte infusion Br J Haematol 2000 108: 116\u2013125","journal-title":"Br J Haematol"},{"key":"BF2402203_CR47","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1053\/bbmt.1999.v5.pm10465105","volume":"5","author":"DL Porter","year":"1999","unstructured":"Porter DL, Collins RH, Shpilberg O, Drobyski WR, Connors JM, Sproles A, Antin JH . Long-term follow-up of patients who achieved complete remission after donor leukocyte infusions Biol Blood Marrow Transplant 1999 5: 253\u2013261","journal-title":"Biol Blood Marrow Transplant"},{"key":"BF2402203_CR48","doi-asserted-by":"publisher","first-page":"317","DOI":"10.3109\/10428199909167392","volume":"32","author":"A Schattenberg","year":"1999","unstructured":"Schattenberg A, Schaap N, van deWiel van Kemenade E, B\u00e4r B, Preijers F, van der Maazen R, Roovers E, de Witte T . In relapsed patients after lymphocyte depleted bone marrow transplantation the percentage of donor T lymphocytes correlates well with the outcome of donor leukocyte infusion Leuk Lymphoma 1999 32: 317\u2013325","journal-title":"Leuk Lymphoma"},{"key":"BF2402203_CR49","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1182\/blood.V94.2.434","volume":"94","author":"WR Drobyski","year":"1999","unstructured":"Drobyski WR, Hessner MJ, Klein JP, Kabler BC, Vesole DH, Keever TC . T-cell depletion plus salvage immunotherapy with donor leukocyte infusions as a strategy to treat chronic-phase chronic myelogenous leukemia patients undergoing HLA-identical sibling marrow transplantation Blood 1999 94: 434\u2013441","journal-title":"Blood"},{"key":"BF2402203_CR50","first-page":"975","volume":"18","author":"DL Porter","year":"1996","unstructured":"Porter DL, Roth MS, Lee SJ, McGarigle C, Ferrara JL, Antin JH . Adoptive immunotherapy with donor mononuclear cell infusions to treat relapse of acute leukemia or myelodysplasia after allogeneic bone marrow transplantation Bone Marrow Transplant 1996 18: 975\u2013980","journal-title":"Bone Marrow Transplant"},{"key":"BF2402203_CR51","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1200\/JCO.1997.15.2.433","volume":"15","author":"RH Collins","year":"1997","unstructured":"Collins RH, Shpilberg O, Drobyski WR, Porter DL, Giralt S, Champlin R, Goodman SA, Wolff SN, Hu W, Verfaillie C, List A, Dalton W, Ognoskie N, Chetrit A, Antin JH, Nemunaitis J . Donor leukocyte infusions in 140 patients with relapsed malignancy after allogeneic bone marrow transplantation J Clin Oncol 1997 15: 433\u2013444","journal-title":"J Clin Oncol"},{"key":"BF2402203_CR52","doi-asserted-by":"crossref","first-page":"3113","DOI":"10.1182\/blood.V89.9.3113","volume":"89","author":"F Keil","year":"1997","unstructured":"Keil F, Haas OA, Fritsch G, Kalhs P, Lechner K, Mannhalter C, Reiter E, Niederwieser D, Hoecker P, Greinix HT . Donor leukocyte infusion for leukemic relapse after allogeneic marrow transplantation: lack of residual donor hematopoiesis predicts aplasia Blood 1997 89: 3113\u20133117","journal-title":"Blood"},{"key":"BF2402203_CR53","doi-asserted-by":"crossref","first-page":"3582","DOI":"10.1182\/blood.V92.10.3582","volume":"92","author":"H Baurmann","year":"1998","unstructured":"Baurmann H, Nagel S, Binder T, Neubauer A, Siegert W, Huhn D . Kinetics of the graft-versus-leukemia response after donor leukocyte infusions for relapsed chronic myeloid leukemia after allogeneic bone marrow transplantation Blood 1998 92: 3582\u20133590","journal-title":"Blood"},{"key":"BF2402203_CR54","doi-asserted-by":"crossref","first-page":"3671","DOI":"10.1182\/blood.V91.10.3671","volume":"91","author":"EP Alyea","year":"1998","unstructured":"Alyea EP, Soiffer RJ, Canning C, Neuberg D, Schlossman R, Pickett C, Collins H, Wang Y, Anderson KC, Ritz J . Toxicity and efficacy of defined doses of CD4(+) donor lymphocytes for treatment of relapse after allogeneic bone marrow transplant Blood 1998 91: 3671\u20133680","journal-title":"Blood"},{"key":"BF2402203_CR55","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1182\/blood.V76.2.418.418","volume":"76","author":"R Champlin","year":"1990","unstructured":"Champlin R, Ho W, Gajewski J, Feig S, Burnison M, Holley G, Greenberg P, Lee K, Schmid I, Giorgi J . Selective depletion of CD8+ T lymphocytes for prevention of graft-versus-host disease after allogeneic bone marrow transplantation Blood 1990 76: 418\u2013423","journal-title":"Blood"},{"key":"BF2402203_CR56","doi-asserted-by":"crossref","first-page":"4337","DOI":"10.1182\/blood.V86.11.4337.bloodjournal86114337","volume":"86","author":"S Giralt","year":"1995","unstructured":"Giralt S, Hester J, Huh Y, Hirsch-Ginsberg C, Rondon G, Seong D, Lee M, Gajewski J, van Besien K, Khouri I . CD8-depleted donor lymphocyte infusion as treatment for relapsed chronic myelogenous leukemia after allogeneic bone marrow transplantation Blood 1995 86: 4337\u20134343","journal-title":"Blood"},{"key":"BF2402203_CR57","doi-asserted-by":"publisher","first-page":"1719","DOI":"10.1126\/science.276.5319.1719","volume":"276","author":"C Bonini","year":"1997","unstructured":"Bonini C, Ferrari G, Verzeletti S, Servida P, Zappone E, Ruggieri L, Ponzoni M, Rossini S, Marvilio F, Traversari C, Bordignon C . HSV-TK gene transfer into donor lymphocytes for control of allogeneic graft-versus-leukemia Science 1997 276: 1719\u20131724","journal-title":"Science"},{"key":"BF2402203_CR58","doi-asserted-by":"publisher","first-page":"2243","DOI":"10.1089\/hum.1998.9.15-2243","volume":"9","author":"S Verzeletti","year":"1998","unstructured":"Verzeletti S, Bonini C, Marktel S, Nobili N, Ciceri F, Traversari C, Bordignon C . Herpes simplex virus thymidine kinase gene transfer for controlled graft-versus-host disease and graft-versus-leukemia: clinical follow-up and improved new vectors Hum Gene Ther 1998 9: 2243\u20132251","journal-title":"Hum Gene Ther"},{"key":"BF2402203_CR59","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1182\/blood.V94.4.1201","volume":"94","author":"JH Falkenburg","year":"1999","unstructured":"Falkenburg JH, Wafelman AR, Joosten P, Smit WM, van Bergen CAM, Bongaerts R, Lurvink E, van der Hoorn M, Kluck P, Landegent JE, Kluin-Nelemans H, Fibbe WE, Willemze R . Complete remission of accelerated phase chronic myeloid leukemia by treatment with leukemia-reactive cytotoxic T lymphocytes Blood 1999 94: 1201\u20131208","journal-title":"Blood"}],"container-title":["Leukemia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/2402203.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/2402203","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/2402203.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,31]],"date-time":"2022-03-31T22:03:32Z","timestamp":1648764212000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/2402203"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2001,9,1]]},"references-count":59,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2001,9,1]]}},"alternative-id":["BF2402203"],"URL":"https:\/\/doi.org\/10.1038\/sj.leu.2402203","relation":{},"ISSN":["0887-6924","1476-5551"],"issn-type":[{"value":"0887-6924","type":"print"},{"value":"1476-5551","type":"electronic"}],"subject":[],"published":{"date-parts":[[2001,9,1]]},"assertion":[{"value":"30 November 2000","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 May 2001","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 September 2001","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}